These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 23977938)
1. Pseudomonas aeruginosa treatment and transmission reduction. Bowers DR; Tam VH Expert Rev Anti Infect Ther; 2013 Aug; 11(8):831-7. PubMed ID: 23977938 [TBL] [Abstract][Full Text] [Related]
2. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan. Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693 [TBL] [Abstract][Full Text] [Related]
4. Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosa. DeRyke CA; Kuti JL; Nicolau DP Conn Med; 2005 May; 69(5):271-5. PubMed ID: 16114642 [No Abstract] [Full Text] [Related]
5. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249 [TBL] [Abstract][Full Text] [Related]
6. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. Jung R; Fish DN; Obritsch MD; MacLaren R J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239 [TBL] [Abstract][Full Text] [Related]
7. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy]. Sidorenko SV; Gel'fand EB; Mamontova OA Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
9. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Rice LB Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511 [TBL] [Abstract][Full Text] [Related]
10. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media. Jang CH; Park SY Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. Smith RS; Iglewski BH J Clin Invest; 2003 Nov; 112(10):1460-5. PubMed ID: 14617745 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections. Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597 [TBL] [Abstract][Full Text] [Related]
13. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment. Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and future of the aerosoltherapy in the treatment of cystic fibrosis patients infected by Pseudomonas aeruginosa]. Rognon A; Curti C; Montana M; Terme T; Rathelot P; Vanelle P Therapie; 2011; 66(6):481-91. PubMed ID: 22186073 [TBL] [Abstract][Full Text] [Related]
16. An update on antimicrobial resistance and the role of newer antimicrobial agents for Pragasam AK; Veeraraghavan B; Nalini E; Anandan S; Kaye KS Indian J Med Microbiol; 2018; 36(3):303-316. PubMed ID: 30429381 [TBL] [Abstract][Full Text] [Related]
17. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum. Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444 [TBL] [Abstract][Full Text] [Related]
18. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies. Zavascki AP Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266 [No Abstract] [Full Text] [Related]
19. Outbreak of hot-foot syndrome - caused by Pseudomonas aeruginosa. Michl RK; Rusche T; Grimm S; Limpert E; Beck JF; Dost A Klin Padiatr; 2012 Jul; 224(4):252-5. PubMed ID: 22187332 [TBL] [Abstract][Full Text] [Related]